This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Save to my personal folders Download to citation manager Citing Articles Citing Articles via HighWire Google Scholar Articles by Velicer, C. M. Articles by Ulrich, C. M. PubMed PubMed Citation Articles by Velicer, C. M. Articles by Ulrich, C. M.

Vitamin and Mineral Supplement Use Among US Adults After Cancer Diagnosis: A Systematic Review

Christine M. Velicer, Cornelia M. Ulrich

From the Cancer Prevention Program, Fred Hutchinson Cancer Research Center; and the Department of Epidemiology, University of Washington, Seattle, WA

Corresponding author: Cornelia M. Ulrich, PhD, Fred Hutchinson Cancer Research Center, Mail Stop M4-B402, Seattle, WA 98109; e-mail: nulrich{at}fhcrc.org

Vitamin and mineral supplement use is thought to be common among the 10 million adults in the United States who have been diagnosed with cancer; however, well-conducted studies of this topic are sparse. Moreover, the biologic effects of supplement use among cancer survivors are not well established and not necessarily beneficial. We present a systematic summary of studies published between 1999 and 2006, 32 in total, addressing vitamin and mineral supplement use among US adult cancer patients and survivors. Supplement use is widespread among cancer patients and longer-term survivors. In studies combining different cancer sites, 64% to 81% of survivors reported using any vitamin or mineral supplements and 26% to 77% reported using any multivitamins. In contrast, approximately 50% of US adults use dietary supplements and 33% use multivitamin/multimineral supplements. Between 14% and 32% of survivors initiate supplement use after diagnosis, and use differs by cancer site. Breast cancer survivors reported the highest use, whereas prostate cancer survivors reported the least. Higher level of education and female sex emerged as factors most consistently associated with supplement use. Up to 68% of physicians are unaware of supplement use among their cancer patients. These results highlight the need for further studies of the association between dietary supplement use and cancer treatment toxicity, recurrence, survival, and quality of life to support evidence-based clinical guidelines for dietary supplement use among cancer patients and longer-term survivors.

Supported by National Cancer Institute Grants No. NIH CA105437, NIH CA105145, and T32CA091680.

Authors’ disclosures of potential conflicts of interest and author contributions are found at the end of this article.

This article has been cited by other articles:

				C. M. Ulrich and R. S. Holmes Shedding Light on Colorectal Cancer Prognosis: Vitamin D and Beyond J. Clin. Oncol., June 20, 2008; 26(18): 2937 - 2939. [Full Text] [PDF]